Jeff Closs Email & Phone Number

Ancora Heart, a medical device company based in Santa Clara, Calif., is dedicated to helping people with heart failure (HF) and functional mitral regurgitation (FMR) feel better and live longer.The company has developed AccuCinch®, the first percutaneous ventricular repair (PVR) system designed to treat FMR, which is caused by heart failure. AccuCinch.

Digital health Incubator working on novel technology and software for Obstructive Sleep Apnea

BioIQ (http://www.BioIQ.com) is a healthcare technology company that enables organizations to connect with their populations, measure vital health metrics, and achieve health improvement goals. BioIQ works with some of the largest employers and health companies in the nation. Since its inception in 2005, it has launched thousands of successful health.

Mountain View, CA, US

The Angels’ Forum (TAF) is an experienced and engaged group of investors focused on making money from investments in Silicon Valley. Since forming in 1997, TAF has become one of the most respected angel groups in the San Francisco Bay Area. All members have made their own wealth from previous entrepreneurial ventures and/or corporate experience

US

SyncHR is a leading innovator for cloud-based human resources, benefits, and payroll software. SyncHR reinvents how employers manage human capital with an event-driven single application. SyncHR’s patented single database system creates transparency company-wide, improves data integrity and grows as you expand. A BENU subsidiary, syncHR has offices in.

US

Co-founded Benu with New Enterprise Associates, focusing on healthcare. Benu conceptualized, built and operated the first multi-carrier risk adjusted healthcare exchange with national payers (Kaiser, United Healthcare, CIGNA). Identified a unique opportunity to expand consumer choice in healthcare insurance pre-Obama Care e.g healthcare exchanges..

Nellix, Inc, was privately-held medical device company that developed a revolutionary endograft for the treatment of Abdominal Aortic Aneurysms (AAAs). Nellix developed a highly differentiated technology platform that completely seals and fills an aortic aneurysm sac, preventing device migration and potentially improving clinical outcomes. This allows the.

US

Responsible for all activities of start-up stage, venture backed company. The company developed a novel device for the treatment of peripheral and coronary artery disease.

Responsible for all outside the U.S. sales, marketing, regulatory, reimbursement & clinical activities.

Responsible for all European start up operations in manufacturing, regulatory, sales, marketing and clinical. Responsible for CE mark clinical study, including trial design, protocol and data analysis. Identified and started manufacturing operations in Scotland. Conducted early clinical device evaluations with key thought leaders in Europe. Hired direct.

Relocated to London, UK in newly created position to develop and penetrate European market for Directional Coronary Atherectomy. Responsible for European marketing strategy, sales plan and clinical support. Managed distributor network. Transitioned from distributor organizations in France and U.K. to direct DVI organizations.

Managed new product introduction of a innovative interventional cardiology therapy. Trained physicians and hospitals in Georgia, North & South Carolina and North Florida on clinical procedure of Directional Coronary Atherectomy. Finished 1st for total dollar increase and 2nd for % sales increase.

Managed five District Managers in the Southeast region which included Alabama, Florida, Georgia, Carolina's, Maryland, Virginia, Washington D.C. and Eastern Pennsylvania. Managed sales plan of $17 million and operating budget of $1 million. Region finished 1st in company at 108% of plan and largest total revenue.

Appointed to a newly created program and position. Responsible for recruiting new sales associates. Created, developed and conducted a sales training program for sales associates. Developed and conducted sales training programs for the field national sales organization.

Responsible for sales and clinical support of Bentley Labs cardiovascular bypass and surgery products and Edwards Labs tissue and mechanical heart valves. President’s Club member every year. Converted largest non-Bentley account Johns Hopkins Hospital to 100% Bentley products. Johns Hopkins Hospital became the largest revenue account in company history..

Bentley Labs division was a leader in Cardiopulmonary bypass devices and heart valves. Successfully completed sales and clinical training program for District Sales Manager. Assigned to the Mid-Atlantic territory based in Washington D.C.

Master Of Business Administration (M.B.A.)

Bachelor Of Arts (B.A.)